Neuroone Medical Technologies (NMTC) Change in Acquisitions & Divestments (2022 - 2023)
Neuroone Medical Technologies' (NMTC) quarterly Change in Acquisitions & Divestments came in at $1.0 million in Q2 2023, down 50.0% quarter-over-quarter from $2.0 million in Q1 2023.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) Change in Acquisitions & Divestments (2022 - 2023) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported Change in Acquisitions & Divestments for 2 consecutive years, with $1.0 million the latest figure, recorded in Q2 2023.
- For the quarter ending Q2 2023, Change in Acquisitions & Divestments changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Sep 2023 stood at $4.5 million (changed N/A YoY), and the FY2023 full-year result was $4.5 million, up 800.0% from the prior year.
- Change in Acquisitions & Divestments declined to $1.0 million in Q2 2023 per NMTC's latest filing, from $2.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $2.0 million in Q1 2023 and bottomed at $1.0 million in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Neuroone Medical Technologies | 14.33 Mn | 12.29 Mn | 1.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 1.50 Mn |